| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 30.927 | 33.428 | 34.112 | 26.489 | 37.683 | 42.498 | 57.166 | 61.082 |
| Total Income - EUR | - | - | 30.927 | 33.428 | 34.112 | 26.489 | 37.683 | 42.498 | 57.166 | 61.847 |
| Total Expenses - EUR | - | - | 5.242 | 5.968 | 10.327 | 8.238 | 8.122 | 9.204 | 8.424 | 14.005 |
| Gross Profit/Loss - EUR | - | - | 25.685 | 27.459 | 23.785 | 18.251 | 29.561 | 33.294 | 48.742 | 47.842 |
| Net Profit/Loss - EUR | - | - | 25.376 | 27.125 | 23.444 | 17.986 | 29.184 | 32.869 | 48.170 | 46.024 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Endocrinologie Dr. Voicu Florentina S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 25.768 | 34.583 | 34.153 | 24.825 | 29.769 | 35.700 | 48.947 | 48.486 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.368 | 1.977 | 1.744 | 1.632 | 3.001 | 3.337 | 4.369 | 38.638 |
| Cash | - | - | 23.401 | 32.606 | 32.409 | 23.192 | 26.768 | 32.364 | 44.578 | 9.848 |
| Shareholders Funds | - | - | 25.420 | 27.177 | 23.496 | 18.044 | 29.241 | 32.926 | 48.227 | 46.080 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 349 | 7.407 | 10.657 | 6.781 | 528 | 2.775 | 720 | 2.406 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endocrinologie Dr. Voicu Florentina S.r.l.